HOME >> BIOLOGY >> NEWS
Other highlights in the Aug. 7 JNCI

Vitamins and Minerals Showed Little Benefit on Liver Cancer Death Rates

Taking vitamins and minerals did not reduce liver cancer death rates in a study conducted by the National Cancer Institute and the Chinese Academy of Medical Sciences.

Liver cancer is a common cancer with a high death rate. New prevention strategies are needed to reduce the number of deaths from the disease.

Chen-Xu Qu, M.D., and colleagues conducted a randomized clinical trial that examined whether four vitamin-mineral supplement combinations could effect the liver cancer death rate in a Chinese population that was deficient in many vitamins and minerals. Study participants took two or four of the following combinations: retinol and zinc; riboflavin and niacin; ascorbic acid and molybdenum; beta-carotene, alpha-tocopherol, and selenium; or placebo pills.

After 5.25 years, none of the vitamin-mineral combinations caused a statistically significant reduction in liver cancer deaths overall. However, some combinations reduced risk in subgroups defined by age, sex, and alcohol consumption. These subgroup analyses need to be interpreted with caution, the authors write.

Contact: National Cancer Institute press office, ncipressofficers@mail.nih.gov, (301) 496-6641


Prior Testicular Cancer Diagnosis Has Little Impact on Second Cancer Survival

Testicular cancer survivors diagnosed with a second cancer had mortality rates similar to men diagnosed with a first cancer, except among some diagnosed with testicular cancer between 1973 and 1979.

Most testicular cancer patients are cured, but survivors are at a higher risk for second cancers later in life. There is little data on mortality rates of testicular cancer survivors with a second cancer.

Catherine Schairer, Ph.D., of the National Cancer Institute in Bethesda, Md., and colleagues co
'"/>

Contact: Liz Savage
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
7-Aug-2007


Page: 1 2 3

Related biology news :

1. Other highlights in the July 24 JNCI
2. Other highlights from the July 10 JNCI
3. Other highlights in JNCI, June 26
4. Other highlights in JNCI, June 12
5. Other highlights from the June 6 JNCI
6. Other highlights in the May 16 JNCI
7. Other highlights from the April 18 Journal of the National Cancer Institute
8. Other highlights from the March 21 JNCI
9. Other highlights in the March 7 JNCI
10. Other highlights in the Feb. 21 JNCI
11. Other highlights in the Jan. 17 JNCI

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/19/2019)... ... 2019 , ... The Laser Institute (LIA)'s 38th ... held in Orlando, Florida and featured the conference’s many firsts. A meeting of ... with a deeper industry foci, more expansive technical sessions, and a new Business ...
(Date:10/17/2019)... , ... October 15, 2019 , ... ... Media for the Microbiological Community”. , Microbiology International currently manufactures ready-to-use culture broth ... also offers pre-poured agar plates & liquid supplements. , This major step underpins ...
(Date:10/17/2019)... ... October 16, 2019 , ... The International Society for ... Baseline® Guide: Water and Steam Systems (Third Edition) . This guide provides in-depth ... systems. Industry professionals can better understand Good Manufacturing Practices (GMPs), to comply with ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... ... October 01, 2019 , ... Today Cereset®, the ... the midway point of its randomized research trial for individuals with persisting symptoms ... the efficacy of a non-invasive technology which compares tones delivered to a subject’s ...
(Date:10/3/2019)... ... October 02, 2019 , ... Rapid Novor, Inc., the ... that it has moved into a new, 5000 sqft, purpose-built, state-of-the-art facility. Now ... demonstrates the company's continuous commitment to quality research and service offerings. ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer ... focused on the development of therapies to treat central nervous system (CNS) ...
(Date:9/17/2019)... ... 17, 2019 , ... Catalent, a global leader in clinical ... Asia Pacific (APAC) will present at the upcoming 3rd Annual Accelerating Clinical Trials ... On Thursday, Sept. 26, at 10:10 a.m., Ms. Delaney will present “Singapore: APAC’s ...
Breaking Biology Technology:
Cached News: